Aarti Drugs Ltd (NSE: AARTIDRUGS) has been trading within a well-defined parallel channel on the monthly timeframe since 2009. The stock is currently at the bottom of the channel, having successfully retested the channel support. This retest could signify a potential bounce, presenting a long-term buying opportunity.
The RSI is also on an upward trajectory.
Sharing this analysis for Long-Term investors.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research before making any investment decisions.
The RSI is also on an upward trajectory.
Sharing this analysis for Long-Term investors.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research before making any investment decisions.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。